News | Radiation Therapy | October 28, 2015

Cleveland Clinic Nurse Receives 2015 ASTRO Annual Meeting Nurses Abstract Award

Research abstract on post-chemoradiation therapy follow-up for high-risk head and neck patients presented at ASTRO annual meeting

ASTRO, Annual Meeting Nurses Abstract Award, radiation therapy, Bridgett Harr

October 28, 2015 — The American Society for Radiation Oncology (ASTRO) has awarded the 2015 Annual Meeting Nurses Abstract Award to Bridgett Harr, CPN, Cleveland Clinic, Cleveland, for the abstract “Advanced Practice Nurse Follow-up Clinic Reduces Emergency Room Visits and Admissions in High-Risk Patients after Chemoradiation Therapy for Head and Neck Cancer.”

The Annual Meeting Nurses Abstract Award honors the highest rated abstract with a nursing designation. Award candidates must be nurses who are the lead author or co-author of an abstract selected for presentation at the 2015 ASTRO annual meeting. Harr received a $1,000 award, along with a certificate and complimentary annual meeting registration, at ASTRO’s 57th Annual Meeting, Oct. 18-21, in San Antonio.

“Ms. Harr’s abstract exemplifies the best in the nursing abstracts submitted this year for ASTRO’s Annual Meeting,” said ASTRO President Bruce D. Minsky, M.D., FASTRO. “Every year we select an abstract that highlights research showing how nursing can benefit patient care.”

Harr’s abstract will be presented as a poster at the annual meeting.

For more information: www.astro.org

Related Content

RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017
News | Radiation Therapy | September 14, 2017
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
Overlay Init